Close

APPLY NOW

Apply to the Nanomedicine Award 2017 edition

Complete your application before August  15, 2017. You must complete 100% of it to validate the submission of your project.

Two options are available:

  1. Fill the form below, 

    2. Fill the word document and send it back to award@etp-nanomedicine.eu

If needed send an appendix file (figure, picture, other, pdf only)  to award@etp-nanomedicine.eu.


Note: This form automatically saves your input to your browser cache. You can safely navigate to other pages and come back any time to finish the submission. The form will be reset on save or you can also press the “Reset” button to reset all data.


GENERAL INFORMATION

Award Category:

Project Title:

Start of the project:

Application category:

Application therapeutic areas:

Stage of development:

Partner (if relevant):

LEAD ORGANIZATION

Name:

Website:

CONTACT PERSON

Name and position:

Phone number:

E-mail:

1. Abstract: summarize your project or product.

2000

2. Describe which unmet medical need you are addressing.

1500

3. What is the actual offer on the market?

2500

4. Describe your product / project technology.

2500

5. State the advantages of your project or product over existing and/or near-market/in development products.

2500

6. If you are applying for the Best nanomed product/deal award, please describe the type and the terms of the partnership if applicable.

2500

7. Define the regulatory status of your product if you already know it (Drug / Medical Device / Combination).

1000

8. Specify the innovativeness of the project and how nanomedicine is playing a key role in it.

1500

9. Current progress of your innovation: stage of development, present data obtained so far (summary) and your future plan of development. Add latest relevant list of publications.

1500

10. Explain how you have managed intellectual property (IP), the importance of IP to your strategy and add the list of patents.

2000

11. Do you have identified foreseen roadblocks (IP, Technology, manufacturing, payers, management, founding, etc.)?

1500

12. Can you explain the alternative scenarios identified to answer to the foreseen roadblocks.

2000

13. How is the payer perception taken into account in your R&D strategy?

2000

14. Short company / laboratory presentation.

200

15. Are you a member of the European Technologie Platform on Nanomedicine (ETPN)?

16. Are you a member of the Nanomedicines Alliance?

17. Applicants biography and mention any relevant partnering.

2000

18. Comment

2000

 

If needed send an appendix file (figure, picture, other, pdf only)  to award@etp-nanomedicine.eu.